Hummingbird Diagnostics Announces Initiation of Patient Recruitment for Clinical Study Evaluating miLungDx as a Novel Diagnostic Test for Early-stage Lung Cancer
HEIDELBERG, Germany--(BUSINESS WIRE)--Jan 23, 2024--
Source: eagletribune.com
Hummingbird Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hummingbird Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hummingbird Diagnostics Today - Breaking & Trending Today
Hummingbird Diagnostics GmbH: Hummingbird Diagnostics to Present Poster on miLung Small RNA-Based Blood Test at the ASCO 2023 Annual Meeting
Hummingbird Diagnostics GmbH, a leader in reading blood-based small RNAs for early disease detection and characterization, today announced a poster presentation at the American Society for Clinical Oncology
Source: finanznachrichten.de
Hummingbird Diagnostics GmbH: Hummingbird Diagnostics Publishes Study of miRisk as a Predictor of Immunotherapy Efficacy in Advanced-Stage NSCLC
Proprietary microRNA signature (miRisk) may support immunotherapy treatment decisions as a blood-based complementary diagnostic Results published in Journal of Thoracic Oncology Clinical and Research
Source: finanznachrichten.de
Hummingbird Diagnostics GmbH: Hummingbird Diagnostics Announces Publication of Study on the Utility of miRisk, a Blood-based microRNA Analysis, to Predict Overall Survival for Advanced Non-Small Cell Lung Cancer in npj Precision Oncology
-Results describe development of analysis to uncover association of several microRNAs with overall survival following initiation of immunotherapy- -Blood-based test holds potential for broad applicability
Source: finanznachrichten.de